TABLE 2.

Incidence rates per 1,000 persons of COVID‐19 infection in various subgroups

	HCV+ (N = 14,305)
	N	Rate (95% CI)
Overall	892	62.4 (58.4, 66.4)
Males	856	62.5 (58.5, 66.7)
Females	36	59.2 (41.8, 81)
Race
White	251	37.5 (33.1, 42.4)
Black	492	88.4 (81.1, 96.2)
Hispanic	47	79.9 (59.3, 104.9)
Other/unknown	102	69.5 (57, 83.8)
Age group
18‐50	17	24 (14, 38.1)
>50‐60	95	52.7 (42.8, 64)
>60‐70	514	60.7 (55.7, 66)
>70	266	80.1 (71.1, 89.8)
HCV treatment
Untreated	264	64.2 (56.9, 72.2)
Treated with SVR	521	61.4 (56.4, 66.7)
Treated without SVR	47	63.7 (47.2, 83.8)
Treated with SVR missing	60	61.9 (47.5, 78.9)
Liver fibrosis stage
FIB‐4 < 1.45	308	57.6 (51.5, 64.2)
FIB‐4 1.45‐3.25	448	68.9 (62.9, 75.4)
FIB‐4 > 3.25	136	55.3 (46.6, 65.1)
Mortality
Overall	55	3.8 (2.9, 5)
Among hospitalized	32	2.2 (1.5, 3.2)
Among ICU	19	1.3 (0.8, 2.1)